Graham Emslie is a Psychiatry physician affiliated with Children's Medical Center. OpenAlex indexes 342 publications with 18,544 citations (h-index 72); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Child & Adolescent Psychiatry profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd
Dallas, TX 753907208
Telephone
214-645-5900Registry record last updated 1 May 2008.
Clinical trials
- Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
Sponsor: University of Texas Southwestern Medical Center
- Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents
Sponsor: University of Texas Southwestern Medical Center
- Treatment for Adolescents With Depression Study (TADS)
Sponsor: National Institute of Mental Health (NIMH)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 1986–2012 per NIH RePORTER. The latest:
- Pediatric MDD: Sequential Treatment with Fluoxetine and Relapse Prevention CBT
Ut Southwestern Medical Center
FY2012$550,805R01MH039188 - Pediatric MDD: Sequential Treatment with Fluoxetine and Relapse Prevention CBT
Ut Southwestern Medical Center
FY2011$573,981R01MH039188 - Pediatric MDD: Sequential Treatment with Fluoxetine and Relapse Prevention CBT
Ut Southwestern Medical Center
FY2010$583,379R01MH039188
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hopelessness as a Predictor of Suicide Ideation in Depressed Male and Female Adolescent Youth
Suicide and Life-Threatening Behavior
2017 - Sequential Treatment With Fluoxetine and Relapse-Prevention CBT to Improve Outcomes in Pediatric Depression
American Journal of Psychiatry
2014 - A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder
Journal of Child and Adolescent Psychopharmacology
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Farzad Kompani
Children's Medical Center
Sarah Barlow, MD
Children's Medical Center
Marilynn Punaro, MD
Children's Medical Center
Ron Mitchell, MD
Children's Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”